SCHEMBL17431196

SCHEMBL17431196

c1ccc2c(c1)oc1cc3c(cc12)-c1c(ccc2c1sc1ccccc12)-c1ccc2c(sc4ccccc42)c1-c1cc2c(cc1-3)oc1ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 2/20 0.41
▸ MAPT P10636 5/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ESR2 Q92731 1/20 0.39
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ PRKDC P78527 4/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ GPR3 P46089 1/20 0.35
▸ MAOA P21397 2/20 0.35
▸ NTRK1 P04629 1/20 0.33
▸ PLK3 Q9H4B4 1/20 0.33
▸ CDC25A P30304 1/20 0.33
▸ CDC25B P30305 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17431190 1.00 AHR (0.41) AHRMAPTMEN1KMT2AALDH1A1
SCHEMBL17431186 0.81 AHR (0.41) AHRMAPTMEN1KMT2AALDH1A1
SCHEMBL17431205 0.81 AHR (0.41) AHRMAPTMEN1KMT2AALDH1A1
SCHEMBL17431198 0.80 ESR2 (0.40) AHRMAPTALDH1A1HPGDESR2
SCHEMBL17431197 0.80 GPR3 (0.37) AHRMAPTMEN1KMT2AALDH1A1
SCHEMBL17433186 0.79 AHR (0.47) AHRMAPTMEN1KMT2AALDH1A1
SCHEMBL17431203 0.79 AHR (0.47) AHRMAPTMEN1KMT2AALDH1A1
SCHEMBL17431188 0.79 AHR (0.47) AHRMAPTMEN1KMT2AALDH1A1
SCHEMBL17944005 0.77 PRKDC (0.41) AHRMAPTMEN1KMT2AALDH1A1
SCHEMBL18666098 0.77 AHR (0.42) AHRMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10566546-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-02-18 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, NR4A3, OXSR1 AHR 1844/4885MAPT 4272/4885MEN1 2326/4885
US-10566546-B2 Organic electroluminescent materials and devices OXER1, NR4A3, OXSR1 AHR 1844/4885MAPT 4272/4885MEN1 2326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback